M D'Incalci1, G Balconi, M Broggini
1Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Developing selective anticancer agents involves targeting cancer cells for distribution or selective killing. Novel strategies leverage increased biological knowledge of human tumors for improved cancer therapies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: